Prevent Blindness and Bausch + Lomb to Launch Year-Long Video Series to Raise Awareness of Age-Related Macular Degeneration (AMD)
Bausch Health (BHC) and Prevent Blindness are launching a year-long video series during AMD Awareness Month to raise awareness about Age-Related Macular Degeneration (AMD), affecting around 16 million Americans. This marks the sixth consecutive year of their collaboration. The campaign will feature real-life stories of individuals managing AMD and will include a social media donation initiative, contributing $1 for each share or like on relevant Facebook posts, up to $50,000. The initiative aims to educate the public on AMD while encouraging eye examinations.
- Collaborative campaign with Prevent Blindness to raise awareness about AMD.
- Launch of a year-long video series featuring personal stories of AMD patients.
- Donation initiative of up to $50,000 to support Prevent Blindness for social media engagement.
- None.
Organizations Also Launch Social Media Donation Campaign to Support Prevent Blindness' Sight-Saving Fund During February's AMD Awareness Month
BRIDGEWATER, N.J., and CHICAGO, Feb. 1, 2021 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), and Prevent Blindness, the nation's oldest volunteer eye health non-profit organization, today announced they are joining together for the sixth consecutive year during AMD Awareness Month to raise awareness of Age-Related Macular Degeneration (AMD), one of the leading causes of vision loss in adults 50 years of age and older. The two organizations will launch a year-long video series which will feature the personal stories of people who have AMD and the strategies they have for living a healthy lifestyle with the first episode launching later this month.
"Every February for the past six years, we have collaborated with Prevent Blindness to raise awareness of AMD, which affects approximately 16 million people in the United States," said Joe Gordon, U.S. president, Bausch + Lomb. "Beginning this month and through the remainder of 2021, we will release videos that highlight several outstanding people who have been able to successfully manage their AMD diagnosis while continuing to live fulfilling lives. It is our hope that through their stories we can encourage others with AMD, particularly during these times, to take the right actions to help reduce their risk of progression of this debilitating condition."
As part of the launch of the video series, Bausch + Lomb and Prevent Blindness will post a variety of content on their social media pages throughout AMD Awareness Month in February to share facts and helpful information about AMD. Additionally, Bausch + Lomb will donate
"We're very proud of the progress we've made with Bausch + Lomb in raising awareness and providing resources to support people living with AMD. We look forward to expanding our efforts by sharing real-life personal stories," said Jeff Todd, president and CEO, Prevent Blindness. "Even with the impact of the COVID-19 pandemic and some delays in routine care, we hope that these videos, coupled with our social media campaign, will inspire people to schedule a comprehensive dilated eye exam with their doctor – the only way to get properly diagnosed with AMD."
Although there is no cure for AMD, there are steps that patients can take as part of a plan created with their doctor to help reduce their risk of progression. These steps include stopping smoking, exercising regularly, maintaining a healthy diet, and receiving a dilated eye exam.
Patients can also talk to their doctor about taking a vitamin based on the AREDS2 study. Only PreserVision® AREDS 2 formula eye vitamins contain the exact nutrient formula recommended by the National Eye Institute to help reduce the risk of moderate to advanced AMD progression.
To watch the video series and find more information on AMD, visit www.SightMatters.com. For a free listing of organizations and services that provide financial assistance for vision care in English or Spanish, please visit Prevent Blindness at https://www.preventblindness.org/vision-care-financial-assistance-information.
About AMD
AMD is an eye disease that affects the macula, the part of the eye that supports sharp, central vision needed for seeing objects clearly. Early-stage AMD often does not present any symptoms or changes in vision, as symptoms usually appear gradually over time. This progressive condition can impact one or both eyes, causing people to have difficulty with daily activities like driving, reading or recognizing the faces of loved ones.
About Prevent Blindness
Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at preventblindness.org, and follow us on Facebook, Twitter, Instagram and LinkedIn.
About Bausch + Lomb
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., is solely focused on helping people see. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in approximately 100 countries. For more information, visit www.bausch.com.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.
Forward-looking Statements
This news release may contain forward-looking statements, which may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch Health's most recent annual report on Form 10-K and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving COVID-19 pandemic, and the fear of that pandemic and its potential effects, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on Bausch Health, including but not limited to its project development timelines, and costs (which may increase). Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
*Bausch + Lomb will donate
PreserVision is a trademark of Bausch & Lomb Incorporated or its affiliates.
AREDS2 is a registered trademark of the United States Department of Health and Human Services (HHS).
All other product/brand names and/or logos are trademarks of the respective owners.
© 2021 Bausch & Lomb Incorporated or its affiliates.
PV2.0024.USA.21
Prevent Blindness Media Contact: | Bausch Health Investor Contact: |
Sarah Hecker | Arthur Shannon |
(312) 363-6035 | (514) 865-3855 |
(877) 281-6642 (toll free) | |
Bausch Health Media Contact: | |
Lainie Keller | |
(908) 927-1198 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/prevent-blindness-and-bausch--lomb-to-launch-year-long-video-series-to-raise-awareness-of-age-related-macular-degeneration-amd-301218561.html
SOURCE Bausch Health Companies Inc.
FAQ
What is the purpose of the Bausch Health and Prevent Blindness campaign?
How much will Bausch Health donate for each social media engagement?
When does the awareness campaign for AMD begin?
What is Age-Related Macular Degeneration (AMD)?
Who is involved in the AMD awareness initiative?
